Canada Markets open in 3 hrs 2 mins

Amarin Corporation plc (AMRN)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
3.6900+0.1200 (+3.36%)
At close: 04:00PM EST
3.6600 -0.03 (-0.81%)
After hours: 07:53PM EST
Sign in to post a message.
  • t
    thomas
    Old news but ok to report it again
    Sarissa unveiled owning 8.5M shares, or a 2.15%, stake in Amarin, according to a 13-F filing.
    Recall in June the Supreme Court rejected the Amarin's (AMRN) bid to revive Vascepa patents. In March 2020, the US District Court of Nevada stuck down the patents, ruling in favor of two generic manufacturers of Vascepa.
    Sarissa could could try to pressure Amarin (AMRN) to seek licensing partners in Europe or the activist may even push for a sale, Dealreporter speculated today.
    Sarissa, run by Alex Denner, is known for activist positions in companies such as The Medicines Co., Ironwood Pharmaceuticals and Alkermes.
  • a
    art
    From Marjac
    Quick Rule 60 Update:

    On Saturday I mailed the Court a package weighing 41 lbs, 6 oz, containing six full sets of our Briefs and Appendix.

    In terms of current oral argument conflict dates, I am conflicted with April due to a jury trial, while arguing counsel for Reddys is conflicted with July due to a jury trial. Interestingly, Hikma's counsel did not file a scheduling conflicts notice by yesterday's deadline, which likely means that Reddys' counsel will be handling the argument.

    The first weeks of February, March, May, and June remain open for oral argument. We now await word from the Court.
  • C
    Chromosome
    From Leerink

    Highlights
    Big Biopharma will have $500B in gross cash to deploy YE22; Most companies have at least $20B; Major M&A expected
    JNJ, Pfizer and Novartis were called out with the big largest theoretical "M&A Capacity" of $150bn each
    Roche, Merck, BMS, GSK and AbbVie all with over $100bn each
  • D
    Drill-Horizontal
    They say a lot of this big move in the market is all the company stock buybacks. Hello? Amarin?
  • P
    Paul
    Somebody just sold 3000 Jan 7 puts for 4 bucks...interesting
  • S
    SteveM
    ah, today the sellers turn the tables and sell at the end of the day to drive the low-volume based price back down. LOL - it;s been the other way around for a while.
  • D
    Drill-Horizontal
    Interesting day and trend. At least the Mute button works. I would hate to be that guy posting he was shorting Amarin down here. Did SV return to post? I think I muted that noise. But usually he returns on an uptrend.

    On a more serious note, anyone buying call options?
  • P
    Paul
    Please note: Amazon Pharmacy-scroll to High Cholesterol- Vascepa 1 g 90 day supply $167 with prescription. Sales will increase tremendously. (Amazon member price)
  • N
    Niall
    How long has it been since we had a green day? It seems like forever. Hopefully it’s the start of a true renaissance.
  • M
    Mike
    One of NASDAQs big gainers of the day! Great move AMRN!!!
  • S
    SteveM
    not a lot of selling to counter the buying today - something might be happening
  • G
    G.Growl
    HLS Therapeutics to Present at Stifel GMP's Future of Healthcare Conference Dec 8 at 10.30 Eastern
    Maybe Pfizer made some progress despite Covid Delta variant hitting at the worst time for in person marketing
  • t
    tripsdad97
    Three days in a row closing at $3.57. What are the odds?

    Have we reached equilibrium between the retail investors' tax selling, margin calls, and flat out capitulation and the quietly accumulating hedge funds?
  • F
    FrankJ
    At some point Karim may wake up from his JT-like CEO coma and start advertising the merits of this company. There really is quite a bit to let the world better understand.
  • a
    art
    Interesting development on rule 24/60 appeal, post below:
    Update on Rule 60 Appeal Scheduling:

    The electronically filed Reply Brief and Appendix have been accepted by the Court. We now have 5 days to mail hard copies to the Court.

    Of particular interest, arguing counsel has been directed to notify the Court of any scheduling conflicts with any of the listed oral argument dates which all take place within the first 10 days of the following months in 2022:

    February, March, April, May, June, July.

    Thus oral argument could take place as early as the week of February 7-11, 2022, or as late as the week of July 5-8, 2022. I will let he Board know when we have a specific date.
  • J
    James
    nice to see the small increase in the SP .. however it would be more convincing if the volume was stronger .. at least trade the daily average .. it will take a while before we see a swing in the positive direction .. too much negativity to overcome .. but not impossible
  • G
    Gregory
    any bonuses and options for directors and CEO must be eleminated until pps goes north of $27 per share.
  • T
    TBone
    Law offices of Likmi and Dye just won't go away.
  • F
    Franz
    No legitimate reason to be trading for pennies on the dollar. Brand new, copyright protected markets all over Europe, China sales partnership, PFE partnership in Canada, new leadership, new indications for PAD, skinny label protections improving, proven reduction in Triglycerides, potential indications for pancreatitis, arthritis. diabetes, and even Covid, but most importantly, an FDA approved drug that is proven to reduce the chance of an additional CVE in those with previous events, on statins, or with PAD by 25%+!!! Willing to wait this one out folks, and I've accumulated a lot of shares on this downward trend. Stock trades in 100th of pennies, so we know it is programmed algorithm trading. It will run soon, imo. Too much good stuff going on not to. we'll just have to wait and see. Good luck longs, and Happy Holidays!